Kamdar Kim P.
Related Filers (29)
- Evofem Biosciences, Inc. (14)
- VITULLO NICOLE (11)
- Halak Brian K (11)
- DOMAIN ASSOCIATES (11)
- BLAIR JAMES C (11)
- DOVEY BRIAN H (11)
- TREU JESSE I (10)
- OBALON THERAPEUTICS INC (10)
- Singular Genomics Systems, Inc. (8)
- SCHOEMAKER KATHLEEN K (7)
- SERA PROGNOSTICS, INC. (5)
- Tobira Therapeutics, Inc. (3)
- Durata Therapeutics, Inc. (2)
- Ocera Therapeutics, Inc. (2)
- CADENCE PHARMACEUTICALS INC (2)
- Syndax Pharmaceuticals Inc (2)
- Clovis Oncology, Inc. (1)
- Orexigen Therapeutics, Inc. (1)
- ACHILLION PHARMACEUTICALS INC (1)
- ZOGENIX, INC. (1)
- Celator Pharmaceuticals Inc (1)
- Esperion Therapeutics, Inc. (1)
- Evoke Pharma Inc (1)
- Aldeyra Therapeutics, Inc. (1)
- MARINUS PHARMACEUTICALS INC (1)
- aTYR PHARMA INC (1)
- GLAUKOS Corp (1)
- Shah Nimesh (1)
- BioNano Genomics, Inc (1)
- Show More ...
Other (5)
144
Thursday, 12/14/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 12/14/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/15/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/14/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 8/11/2023
Filing for proposed sale of securities under Rule 144
Ownership (55)
4
Friday, 12/22/2023
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Singular Genomics Systems, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
SERA PROGNOSTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/26/2023
Singular Genomics Systems, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
SERA PROGNOSTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/31/2022
Singular Genomics Systems, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/6/2022
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/14/2021
SERA PROGNOSTICS, INC.: Initial statement of beneficial ownership of securities
4
Monday, 6/21/2021
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/1/2021
Singular Genomics Systems, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/26/2021
Singular Genomics Systems, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/13/2021
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/18/2020
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/13/2020
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/8/2019
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/25/2019
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/7/2019
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/23/2019
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/27/2018
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/21/2018
BioNano Genomics, Inc: Initial statement of beneficial ownership of securities
4
Friday, 6/15/2018
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/10/2018
Evofem Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2017
Neothetics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/19/2017
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 5/15/2017
Neothetics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/11/2017
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2016
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2016
Tobira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/2/2016
Syndax Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 10/14/2016
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/5/2016
OBALON THERAPEUTICS INC: Initial statement of beneficial ownership of securities
4
Thursday, 6/23/2016
Neothetics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/2/2016
Syndax Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 6/24/2015
GLAUKOS Corp: Initial statement of beneficial ownership of securities
4
Thursday, 6/18/2015
Neothetics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/6/2015
Tibira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/6/2015
aTYR PHARMA INC: Initial statement of beneficial ownership of securities
3
Wednesday, 11/19/2014
Neothetics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 11/18/2014
Durata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/31/2014
MARINUS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Thursday, 5/1/2014
Aldeyra Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 3/21/2014
CADENCE PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/24/2013
Evoke Pharma Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 8/21/2013
Regado Biosciences Inc: Initial statement of beneficial ownership of securities
3
Tuesday, 7/16/2013
Ocera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 6/25/2013
Esperion Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 1/15/2013
Celator Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 7/18/2012
Durata Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 1/17/2012
ZOGENIX, INC.: Initial statement of beneficial ownership of securities
3
Tuesday, 1/17/2012
CADENCE PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Tuesday, 1/17/2012
Orexigen Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 1/17/2012
ACHILLION PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Wednesday, 11/16/2011
Clovis Oncology, Inc.: Initial statement of beneficial ownership of securities